1. Approval for ketorolac to be withdrawn in Germany

   News item 08 February 2013 Pages: 2 - 2

2. Cefetamet pivoxyl safe and effective

   Review 08 February 2013 Pages: 2 - 2

3. Does the age of starting OC use affect breast cancer risk?

   Correspondence 08 February 2013 Pages: 3 - 3

4. Maternal indomethacin use should be restricted to gestational ages ≪ 32 weeks

   Incidence study 08 February 2013 Pages: 3 - 3

5. Product news: Postmarketing monitoring of moclobemide

   Clinical study 08 February 2013 Pages: 3 - 3

6. UK Government says `no' to Halcion® – for the last time?

   News item 08 February 2013 Pages: 3 - 3

7. Does myopathy result from HIV or zidovudine?

   Incidence study 08 February 2013 Pages: 4 - 4

8. Incidence of neutropenia with clozapine.

   News item 08 February 2013 Pages: 4 - 4

9. Low cardiac risk with sumatriptan – but be careful

   Comment 08 February 2013 Pages: 4 - 4

10. Product news: Zidovudine pharmacokinetics are unaltered in pregnant women,

    Clinical study 08 February 2013 Pages: 4 - 4

11. Somatropin treatment increased lipoprotein (a) levels

    Clinical study 08 February 2013 Pages: 4 - 4

12. ACE inhibitors

    Incidence study 08 February 2013 Pages: 5 - 5

13. Acitretin

    Case report 08 February 2013 Pages: 5 - 5

14. Antineoplastics

    Case report 08 February 2013 Pages: 5 - 5

15. Antipsychotics

    Incidence study 08 February 2013 Pages: 5 - 5

16. Bismuth subgallate

    Case report 08 February 2013 Pages: 5 - 5

17. Cisplatin

    Case report 08 February 2013 Pages: 6 - 6

18. Clozapine

    Case report 08 February 2013 Pages: 6 - 6

19. Clozapine

    Case report 08 February 2013 Pages: 6 - 6

20. Colfosceril palmitate

    Clinical study 08 February 2013 Pages: 6 - 6

21. Cyclophosphamide

    Case report 08 February 2013 Pages: 6 - 6

22. Cyclosporin

    Incidence study 08 February 2013 Pages: 6 - 6

23. Cyclosporin

    Case report 08 February 2013 Pages: 7 - 7

24. Cyclosporin interaction

    Case report 08 February 2013 Pages: 7 - 7

25. Diphtheria, tetanus and pertussis vaccine

    Clinical study 08 February 2013 Pages: 7 - 7

26. Dipyridamole

    Incidence study 08 February 2013 Pages: 7 - 7

27. Dipyrone

    Case reports 08 February 2013 Pages: 7 - 7

28. Droperidol

    Case report 08 February 2013 Pages: 7 - 7

29. Fluoxetine

    Case report 08 February 2013 Pages: 7 - 7

30. Fluoxetine

    Case report 08 February 2013 Pages: 8 - 8

31. Flupenthixol

    Case report 08 February 2013 Pages: 8 - 8

32. Granulocyte macrophage colony-stimulating factor

    Case reports 08 February 2013 Pages: 8 - 8

33. Heparin

    Case report 08 February 2013 Pages: 8 - 8

34. Heparin

    Incidence study 08 February 2013 Pages: 8 - 8

35. Hydrochlorothiazide

    Case report 08 February 2013 Pages: 8 - 8

36. Imipenem/cilastatin

    Incidence study 08 February 2013 Pages: 8 - 8

37. Imipenem + cilastatin

    Case report 08 February 2013 Pages: 9 - 9

38. Interferon alpha 2A

    Case reports 08 February 2013 Pages: 9 - 9

39. Isoniazid

    Case report 08 February 2013 Pages: 9 - 9

40. Lithium

    Case report 08 February 2013 Pages: 10 - 10

41. Methotrexate

    Case report 08 February 2013 Pages: 10 - 10

42. Methotrexate

    Case report 08 February 2013 Pages: 10 - 10

43. Morphine

    Correspondence 08 February 2013 Pages: 10 - 10

44. Nitrofural

    Case report 08 February 2013 Pages: 10 - 10

45. Omeprazole

    Case reports 08 February 2013 Pages: 10 - 10

46. Pentamidine

    Case reports 08 February 2013 Pages: 10 - 10

47. Phenolphthalein

    Case report 08 February 2013 Pages: 10 - 10

48. Propranolol

    Case report 08 February 2013 Pages: 10 - 10

49. Roxithromycin

    Case report 08 February 2013 Pages: 11 - 11

50. Salicylates

    Case report 08 February 2013 Pages: 11 - 11